Phase I/II Study of PDR001 in Patients With Advanced Malignancies

Clinical trial NCT02404441 · COMPLETED

Trial details

NCT number: NCT02404441
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma Non-small Sell Lung Cancer (NSCLC)Triple Negative Breast Cancer Anaplastic Thyroid Cancer Other Solid Tumors

Start date: 2015-04-27
Primary completion: 2020-07-21
Enrollment: 319

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.